## REVIEWER A — Domain Expert

**Impact:** 4 – The primary impact is de‑risking a larger, fundable experiment. This is a legitimate and important goal, though the project itself produces no new biological insight. The cost‑benefit argument is reasonable and conservative.  
**Approach:** 5 – Exceptionally thorough and well‑structured. The inclusion of a rule‑based fallback, three operating modes, a validated safety watchdog, and independent human evaluation demonstrates a mature engineering mindset.  
**Innovation:** 3 – The integration of a large language model (Claude) with a router (DeepSeek) for real‑time microscopy control is novel, but not a fundamental breakthrough. Similar AI‑agent approaches are emerging in automated labs.  
**Preliminary Data:** 5 – Extensive and convincing. The prerequisite static demo, dynamic *Elodea* test (10 min, passed), watchdog validation (100% detection), and blinded human evaluation (κ=0.84) exceed typical preliminary data for a concept project.  
**PI & Team:** 4 – The PI has relevant hardware integration experience. The AI expertise gap is partially addressed through training and collaboration, but the team remains thin (1 intern, ad‑hoc consultants).  
**Feasibility:** 5 – Most milestones are already completed. The remaining 7‑day stress test is low‑risk given the strong prior validations.  
**Experimental Design:** 5 – Clear success criteria, controls (static beads, zero‑move baseline, human‑operated loop, fallback comparison), pre‑registration, and reproducibility measures are all in place.  
**Budget:** 5 – Very modest and fully justified. Contingency is appropriate. Loaner agreement mitigates catastrophic risk.  
**Clarity:** 5 – Exceptionally well‑organized, detailed, and version‑controlled. Every aspect is documented and cross‑referenced.  
**Ethics:** 5 – Low‑risk plant system, strict laser safety, open‑source release.  
**Overall:** 5 – This is a model commissioning project. It fully achieves its stated goal of validating an AI‑driven microscopy platform before investing in expensive biology.  

**Score Sum: 51/55**

---

## REVIEWER B — Fluff/Impact Auditor

**Impact:** 3 – The direct impact is limited (no biological discovery). The claim of protecting a $80k+ investment is plausible but not rigorously quantified. The “15–25% cost overrun reduction” is a benchmark estimate, not a proven outcome. Community adoption is minimal (2 GitHub stars).  
**Approach:** 4 – The approach is sound, but perhaps over‑engineered for a simple commissioning task. A basic rule‑based controller might have sufficed; the AI agent adds complexity and dependency on proprietary APIs (Claude, DeepSeek).  
**Innovation:** 2 – Using off‑the‑shelf LLMs for tool calling in microscopy is not novel. The value lies in the careful validation, not in the core technology.  
**Preliminary Data:** 4 – The data are solid, but they are essentially *final* data for this phase. The proposal is almost a retrospective report, which weakens the case for new funding.  
**PI & Team:** 3 – The PI’s AI expertise is minimal despite a Coursera specialization. The team relies on ad‑hoc consultants; the undergraduate intern has no prior experience. Key‑person risk is high.  
**Feasibility:** 4 – The project is already largely executed, so feasibility is proven. However, the 7‑day stress test is still pending, and long‑term reliability is unvalidated.  
**Experimental Design:** 4 – Well‑designed but the dynamic test was only 10 minutes. The 24‑hour and 7‑day tests are not yet done. The independent evaluation used only 100 decision points from a single run.  
**Budget:** 5 – $4,656 is extremely low. No waste or fluff.  
**Clarity:** 5 – Impeccably clear and comprehensive.  
**Ethics:** 5 – No concerns.  
**Overall:** 3 – The project is competent but lacks the novelty and impact expected of a fundable grant. It reads more as a completion report than a forward‑looking proposal. If reframed as a preliminary study for a larger application, it would be stronger.  

**Score Sum: 42/55**

---

## REVIEWER C — Red Team

**Impact:** 2 – The project has zero scientific output on its own. The impact on Experiment A is indirect and uncertain. The proposal does not convincingly show that the AI agent is essential (a rule‑based controller achieves 89% correct decisions with zero unsafe moves).  
**Approach:** 3 – Heavy reliance on proprietary, closed‑source APIs (Claude, DeepSeek) creates a serious dependency and reproducibility risk. The watchdog test used *synthetic* agent‑generated unsafe commands – real hallucination patterns may differ. The dynamic test is too short to reveal fatigue or drift in agent behavior.  
**Innovation:** 2 – Combination of existing components; no algorithmic or hardware novelty. The field already has automated microscopy with machine‑learning‑based tracking (e.g., CellProfiler, TrackMate).  
**Preliminary Data:** 4 – Good volume, but note that most of the “preliminary data” are the actual project deliverables. The proposal appears to be asking for funding after the work is done. The 10‑minute dynamic run is not a rigorous stress test.  
**PI & Team:** 2 – The PI has limited AI/ML background (one Coursera specialization, 6 months collaboration with a community member). The undergraduate intern is in training. Consultants are ad‑hoc; no formal commitment for long‑term support. Small team with high key‑person risk.  
**Feasibility:** 3 – The core loop works, but the 7‑day continuous run has not been attempted. No plan for handling long‑term drifts, network outages (API calls), or software updates. The fallback controller is a backup but reduces value of the AI component.  
**Experimental Design:** 3 – Weak statistical foundation. Single run, no biological replicates (though plant cells are not the focus). The 100‑decision independent evaluation gives a κ=0.84, but the confidence interval (0.76–0.92) is wide. The stress test schedule is aggressive.  
**Budget:** 4 – Low cost is good, but why is new funding needed if most hardware is already acquired? The $456 increase is covered by discretionary funds, so the request is minimal.  
**Clarity:** 5 – Excellent documentation.  
**Ethics:** 5 – No issues.  
**Overall:** 2 – This is not a grant proposal in the traditional sense; it is a *completion report* for an internal commissioning project. As a funding request, it lacks a clear need for new money (the work is essentially done) and does not present a compelling forward‑looking research question. The project would be better positioned as a preliminary result within a full proposal for Experiment A.

**Score Sum: 35/55**

---

## Combined Verdict

**Combined Score: MIN = 35/55**

**Recommendation:** Major Revisions

**Top 3 Actions:**
1. **Reframe the narrative as a proposal for the final validation phase (7‑day stress test and documentation) with clear justification of why additional funding is needed now** – the current document reads as a completed project report; a grant proposal must articulate what remains to be done and why external support is necessary.
2. **Address the dependency on proprietary AI APIs** – provide a concrete plan for ensuring long‑term reproducibility (e.g., fallback to open‑source models, containerization, or API‑independent logging). Also discuss how agent performance will be maintained when APIs change.
3. **Strengthen the connection to future science** – while Experiment 0 is valuable de‑risking, the proposal must convince reviewers that the investment directly enables a specific, fundable next step (Experiment A). Include a brief outline of Experiment A’s specific requirements and how Phase 0 milestones guarantee them.